Vosoritide
ATC M05BX07 · 6 markets · 19 records
AU 7 records · 4 strengths
- 1.2 mginjectionVOXZOGO 1.2mgVOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe
- 0.56 mginjectionVOXZOGO 1.2mgVOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe
- 0.4 mginjectionVOXZOGO 1.2mgVOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 3 records · 3 strengths
- 1.2 mgpowderVOXZOGO 1.2mg
- 0.56 mgpowderVOXZOGO 1.2mg
- 0.4 mgpowderVOXZOGO 1.2mg
HK 3 records · 1 strengths
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 3 records · 3 strengths
- 1.2 mginjectionVOXZOGO 0,4 mg, poudre et solvant pour solution injectable
- 0.56 mginjectionVOXZOGO 0,4 mg, poudre et solvant pour solution injectable
- 0.4 mginjectionVOXZOGO 0,4 mg, poudre et solvant pour solution injectable
TW 2 records · 2 strengths
- 2 mginjectionVoxzogo powder and solvent for solution for injection 2 mg/ml扶佐高凍晶注射劑2毫克/毫升
- 0.8 mginjectionVoxzogo powder and solvent for solution for injection 2 mg/ml扶佐高凍晶注射劑0.8毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | CA | AU | TW | HK | EU | FR |
|---|---|---|---|---|---|---|
| 1.2 mg injection | VOXZOGO 1.2mg VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe | VOXZOGO 0,4 mg, poudre et solvant pour solution injectable | ||||
| 0.56 mgRecorded as: 560 microgram injection | VOXZOGO 1.2mg VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe | VOXZOGO 0,4 mg, poudre et solvant pour solution injectable | ||||
| 0.4 mgRecorded as: 400 microgram injection | VOXZOGO 1.2mg VOXZOGO vosoritide 0.4 mg powder for injection vial and diluent pre-filled syringe | VOXZOGO 0,4 mg, poudre et solvant pour solution injectable | ||||
| 2 mg injection | Voxzogo powder and solvent for solution for injection 2 mg/ml 扶佐高凍晶注射劑2毫克/毫升 | |||||
| 0.8 mg injection | Voxzogo powder and solvent for solution for injection 2 mg/ml 扶佐高凍晶注射劑0.8毫克/毫升 | |||||
| 1.2 mg powder | VOXZOGO 1.2mg | |||||
| 0.56 mg powder | VOXZOGO 1.2mg | |||||
| 0.4 mg powder | VOXZOGO 1.2mg | |||||
unknown | VOXZOGO 1.2mg | VOXZOGO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 0.4MG | VOXZOGO 1.2mg |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.